|
|
||||||||
Animal: RNA Viruses |
Department of Molecular Genetics and Microbiology, School of Medicine, State University of New York at Stony Brook, Stony Brook, NY 11794, USA1
Biochemistry and Molecular Biology, Chiron Corporation, Emeryville, CA 94608, USA2
Author for correspondence: Eckard Wimmer. Fax +1 631 632 8891. e-mail ewimmer{at}ms.cc.sunysb.edu
Poliovirus proteinase 2Apro is an essential enzyme involved in cleavages of viral and cellular proteins during the infectious cycle. Evidence has been obtained that 2Apro is also involved in genome replication. All enteroviruses have a negatively charged cluster of amino acids at their C terminus (EE/DE/DAMEQNH2), a common motif suggesting function. When aligned with enterovirus sequences, the 2Apro proteinase of human rhinovirus type 2 (HRV2) has a shorter C terminus (EE...QNH2) and, indeed, the HRV2 2Apro cannot substitute for poliovirus 2Apro to yield a viable chimeric virus. Here evidence is provided that the C-terminal cluster of amino acids plays an unknown role in poliovirus genome replication. Deletion of the EEAME sequence from poliovirus 2Apro is lethal without significantly influencing proteinase function. On the other hand, addition of EAME to HRV2 2Apro, yielding a C terminus of this enzyme of EEEAMEQ, stimulated RNA replication of a poliovirus/HRV2 chimera 100-fold. The novel role of the C-terminal sequence motif is manifested at the level of protein function, since silent mutations in its coding region had no effect on virus proliferation. Poliovirus type 1 Mahoney 2Apro could be provided in trans to rescue the lethal deletion EEAME in the poliovirus variant. Encapsidation studies left open the question of whether the C terminus of poliovirus 2Apro is involved in particle formation. It is concluded that the C terminus of poliovirus 2Apro is an essential domain for viral RNA replication but is not essential for proteolytic processing.
This article has been cited by other articles:
![]() |
J. M. Morrison and V. R. Racaniello Proteinase 2Apro Is Essential for Enterovirus Replication in Type I Interferon-Treated Cells J. Virol., May 1, 2009; 83(9): 4412 - 4422. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Khan, X. Peng, J. Yin, P. Zhang, and E. Wimmer Characterization of the New World Monkey Homologues of Human Poliovirus Receptor CD155 J. Virol., July 15, 2008; 82(14): 7167 - 7179. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Huang, D. A. Goff, Q. Huang, A. Martinez, X. Xu, S. Crowder, S. D. Issakani, E. Anderson, N. Sheng, P. Achacoso, et al. Discovery and Characterization of Substituted Diphenyl Heterocyclic Compounds as Potent and Selective Inhibitors of Hepatitis C Virus Replication Antimicrob. Agents Chemother., April 1, 2008; 52(4): 1419 - 1429. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Graci, D. A. Harki, V. S. Korneeva, J. P. Edathil, K. Too, D. Franco, E. D. Smidansky, A. V. Paul, B. R. Peterson, D. M. Brown, et al. Lethal Mutagenesis of Poliovirus Mediated by a Mutagenic Pyrimidine Analogue J. Virol., October 15, 2007; 81(20): 11256 - 11266. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Toyoda, D. Franco, K. Fujita, A. V. Paul, and E. Wimmer Replication of Poliovirus Requires Binding of the Poly(rC) Binding Protein to the Cloverleaf as Well as to the Adjacent C-Rich Spacer Sequence between the Cloverleaf and the Internal Ribosomal Entry Site J. Virol., September 15, 2007; 81(18): 10017 - 10028. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yin, Y. Liu, E. Wimmer, and A. V. Paul Complete protein linkage map between the P2 and P3 non-structural proteins of poliovirus J. Gen. Virol., August 1, 2007; 88(8): 2259 - 2267. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu, D. Franco, A. V. Paul, and E. Wimmer Tyrosine 3 of Poliovirus Terminal Peptide VPg(3B) Has an Essential Function in RNA Replication in the Context of Its Precursor Protein, 3AB J. Virol., June 1, 2007; 81(11): 5669 - 5684. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-K. Lee, K. Kono, E. Haas, K.-S. Kim, K. M. Drescher, N. M. Chapman, and S. Tracy Characterization of an infectious cDNA copy of the genome of a naturally occurring, avirulent coxsackievirus B3 clinical isolate J. Gen. Virol., January 1, 2005; 86(1): 197 - 210. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Samuilova, C. Krogerus, T. Poyry, and T. Hyypia Specific Interaction between Human Parechovirus Nonstructural 2A Protein and Viral RNA J. Biol. Chem., September 3, 2004; 279(36): 37822 - 37831. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Arita, H. Shimizu, and T. Miyamura Characterization of in vitro and in vivo phenotypes of poliovirus type 1 mutants with reduced viral protein synthesis activity J. Gen. Virol., July 1, 2004; 85(7): 1933 - 1944. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yin, A. V. Paul, E. Wimmer, and E. Rieder Functional Dissection of a Poliovirus cis-Acting Replication Element [PV-cre(2C)]: Analysis of Single- and Dual-cre Viral Genomes and Proteins That Bind Specifically to PV-cre RNA J. Virol., May 1, 2003; 77(9): 5152 - 5166. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. D. Zhao and E. Wimmer Genetic Analysis of a Poliovirus/Hepatitis C Virus Chimera: New Structure for Domain II of the Internal Ribosomal Entry Site of Hepatitis C Virus J. Virol., April 15, 2001; 75(8): 3719 - 3730. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |